# A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis

> **NCT03089229** · PHASE1,PHASE2 · COMPLETED · sponsor: **Haus Bioceuticals** · enrollment: 30 (actual)

## Conditions studied

- Atopic Dermatitis
- Eczema

## Interventions

- **DRUG:** HAT01H Cream
- **DRUG:** Vehicle Cream

## Key facts

- **NCT ID:** NCT03089229
- **Lead sponsor:** Haus Bioceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-26
- **Primary completion:** 2017-06-30
- **Final completion:** 2017-07-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03089229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03089229, "A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03089229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*